Rainin Foundation Scientific Advisory Board Member Dr. David Artis’ groundbreaking research has been influential to understanding IBD. In this interview he talks about gut health and disease along with emerging opportunities to support innovation.
The Kenneth Rainin Foundation is pleased to announce that Scott Snapper, MD, PhD, is the new Co-Chair of our Scientific Advisory Board, joining fellow Co-Chair Bana Jabri, MD, PhD.
The G-Tech Medical team discusses the impact of early funding on their “EKG for the gut,” exciting data emerging from current studies and growing interest from researchers and industry.
Our Health grantmaking aims to advance game-changing research that has the potential to improve the lives of people with IBD so it’s thrilling when our grantees gain recognition or high-profile journals publish their findings.
Two of our grantees illustrate distinct and shared ways that the pandemic has disrupted biomedical research and affected the scientific community.
The Foundation made an early Program Related Investment to support Thetis Pharmaceuticals development of a novel therapy for ulcerative colitis, which just reached a new regulatory milestone.
Prominent journals featured cutting-edge advances by five grantees whose research focuses diagnostics, new therapies and biomarkers of mucosal healing that serve patients directly.
We’ve begun a journey of inquiry into the role that the Rainin Foundation can play to address racial disparities in the biomedical enterprise.
The Kenneth Rainin Foundation enhances quality of life by championing the arts, promoting early childhood literacy, and supporting research to cure chronic disease.
©2023-2025 Kenneth Rainin Foundation. All rights reserved.
Privacy Policy
Site by Mission Minded.
Connect with us